NetworkNewsBreaks – Myomo, Inc. (NYSE American: MYO) Featured in Research Note from Sidoti
Earnings Release Myomo, Inc. (NYSE American: MYO) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Myomo’s 3Q:21 Results Exceed Our Estimates; Estimate Expanded Reimbursement Will Fuel 30%-40% Annual Sales Growth In 2022 And 2023; Introduce 2023 Forecast; Maintain BUY, $23 Target.” Click here to access the full report. About Myomo, Inc. Myomo is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to…